Biosimilars featured prominently in research presented at the European League Against Rheumatism's Annual European Congress of Rheumatology. Here are 9 key takeaways from the meeting.
Biosimilars featured prominently in research presented at the European League Against Rheumatism's Annual European Congress of Rheumatology. Here are 9 key takeaways from the meeting.
Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.